European Archives - Page 47 of 1096 - European Medical Journal

Personalised Cancer Vaccine Shows Promising Results in High-Risk Kidney Cancer Trial

Personalised cancer vaccines show promise in preventing recurrence of high-risk kidney cancer, targeting key driver mutations.

Rising Antimicrobial Resistance Poses Threat to Cancer Care

Findings reveal alarmingly high rates of AMR among bacterial pathogens affecting patients with cancer worldwide.

AI Model Predicts Acute Pancreatitis Mortality Better Than Traditional Methods

A machine learning model using XGBoost has been shown to outperform traditional clinical risk scoring systems in predicting mortality risk for ICU patients with acute pancreatitis.

Best Treatments for Androgenetic Alopecia: A Comparison

These findings highlight the effectiveness of low-dose oral minoxidil as an alternative to topical minoxidil.

Key Insights into Stroke Prevention and Treatment

In this episode, Jonathan welcomes Andrew Southerland, a distinguished neurologist and academic leader in the field of vascular neurology. They explore how machine learning is revolutionising prehospital stroke diagnosis, and how innovative strategies like telemedicine can reduce disparities in stroke care.

EMJ Microbiology & Infectious Diseases 6 [Supplement 2] 2025

The possibility of ending the HIV epidemic in Europe is more tangible than ever, but the actions we take now will determine whether we go…

Ending the HIV Epidemic

The possibility of ending the HIV epidemic in Europe is more tangible than ever, but the actions we take now will determine whether we go…

Pulse Wave Velocity Identified as Key Marker of Vascular Ageing

Arterial stiffness, measured by pulse wave velocity, is more strongly linked to ageing than short-term blood pressure variability.

Evaluating Pembrolizumab in First-Line Urothelial Carcinoma Treatment

The results suggest trends towards overall survival and progression-free survival improvements with pembrolizumab in combination with platinum-based chemotherapy.

Pirfenidone for Pulmonary Fibrosis May Also Reduce Lung Cancer Risk

A large-scale study suggests that pirfenidone use in patients with idiopathic pulmonary fibrosis may be linked to a lower incidence of lung cancer.